Trial Search Results
Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery
To evaluate the levels of morphine in a patient's blood when morphine is given into the epidural space in the form of DepoDur® either alone or following a dose of lidocaine also given in the epidural space.
Stanford is currently not accepting patients for this trial.
- Drug: DepoDur following epidural lidocaine
- Drug: DepoDur following spinal anesthetic
Inclusion criteria will include healthy parturients between the ages of 18 and 40 who have
American Society of Anesthesiologists physical status I or II, have an uncomplicated,
singleton, term pregnancy, and are scheduled to undergo cesarean delivery.
Exclusion criteria for the study will included refusal to participate, American Society of
Anesthesiologists physical status III or higher or any severe uncontrolled medical
condition, significant systemic medical or obstetric disease, morbid obesity, opioid,
Nonsteroidal Antiinflammatory Drug (NSAID), or local anesthetic allergy or intolerance,
chronic analgesic or antidepressant use, accidental dural puncture, ineffective spinal or
epidural, and conversion to general anesthesia.
Ages Eligible for Study
18 Years - 40 Years
Genders Eligible for Study